Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance

Journal of Nuclear Medicine

Volumn 47, Issue 4, 2006, Pages 581-586

  Moore, Amelia E B ^a,b   Blake, Glen M ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

99mTc methylene diphosphonate; Bone plasma clearance

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; SCINTILLATION CAMERA; SOFT TISSUE; ULTRAFILTRATION; WHOLE BODY IMAGING; BLOOD; BONE; BONE REMODELING; CLINICAL TRIAL; GLOMERULUS FILTRATION RATE; METABOLISM; MIDDLE AGED; PLASMA; SCINTISCANNING; VALIDATION STUDY;

ADULT; AGED; AREA UNDER CURVE; BLOOD SPECIMEN COLLECTION; BONE AND BONES; BONE REMODELING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PLASMA; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; WHOLE BODY IMAGING;

EID: 33745067549     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mundy GR, Chen D, Oyajobi BO. Bone remodeling. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington DC: American Society for Bone and Mineral Research; 2003:46-58.
2. Recker RR, Barger-Lux MJ. Bone biopsy and histomorphometry in clinical practice. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington DC: American Society for Bone and Mineral Research; 2003:213-219.
3. Recker R, Lappe J, Davies KM, Heaney R. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res. 2004;19:1628-1633.
4. Khosla S, Kleerekoper M. Biochemical markers of bone turnover. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington DC: American Society for Bone and Mineral Research; 2003:166-172.
5. Seibel MJ, Eastell R, Gundberg CM, Hannon R, Pols HAP. Biochemical markers of bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego, CA: Academic Press; 2002:1543-1571.
6. Beck-Jensen JE, Kollerup G, Sorensen HA, et al. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Scand J Clin Lab Invest. 1997;57:351-359.
7. 99mTc-methylene diphosphonate. Semin Nucl Med. 2001;31:28-49.
8. Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. Technetium-99m-methylene diphosphonate: a superior agent for skeletal imaging - comparison with other technetium complexes. J Nucl Med. 1975;16:744-755.
9. 18F-Fluoride for bone imaging. Semin Nucl Med. 1972;2:31-37.
10. Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR. The use of whole-body retention of Tc-99m disphosphonate in the diagnosis of metabolic bone disease. J Nucl Med. 1978;19:270-275.
11. D'Addabbo A, Rubini G, Mele M, et al. A new method of assessing Tc-99m-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal region of interest. Nucl Med Commun. 1992;13:55-60.
12. Brenner W, Bohuslavizki KH, Sieweke N, Tinnemeyer S, Clausen M, Henze E. Quantification of diphosphonate uptake based on conventional bone scanning. Eur J Nucl Med. 1997;24:1284-1290.
13. Scillitani A, Dicembrino F, Chiodini I, et al. Global skeletal uptake of Tc-99m-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover. Osteoporos Int. 2002;13:829-834.
14. 99mTc-MDP. J Nucl Med. 2002;43:338-345.
15. 18F] fluoride kinetics in humans. J Nucl Med. 1978;19:1301-1309.
16. Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun. 2004;25:759-769.
17. Hyldstrup L, McNair P, Ring P, Henriksen O. Studies on diphosphonate kinetics. Part I: Evaluation of plasma elimination curves during 24 h. Eur J Nucl Med. 1987;12:581-584.
18. 99mTc-MDP. J Nucl Med. 2003;44:891-897.
19. 51Cr-EDTA overestimate true renal clearance by 10 percent. Eur J Nucl Med. 2003;30:4-8.
20. Peters AM. Graphical analysis of dynamic data: the Patlak-Rutland plot. Nucl Med Commun. 1994;15:669-672.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307-310.
22. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in C: The Art of Scientific Computing. 2nd ed. Cambridge, U.K.: Cambridge University Press; 1992:689-698.
23. Hyldstrup L, McNair P, Ring P, Henriksen O. Studies on diphosphonate kinetics. Part II: whole body bone uptake rate during constant infusion - a refined index of bone metabolism. Eur J Nucl Med. 1987;12:585-588.
24. Fogelman I, Martin W. Assessment of skeletal uptake of Tc-99m disphosphonate over a five-day period. Eur J Nucl Med. 1983;8:489-490.